For instance, Zhou et al. [36] reported that GPC3-targeted PET imaging not only improves early HCC detection- but also effectively predicts the prognosis of anti-GPC3 cytotoxic antibody immunotoxin therapies. The gene discussed is GPC3; the disease is hepatocellular carcinoma.